文献速递糖尿病

血清半乳糖凝集素-3与儿童期起病1型糖尿病受试者后续冠心病风险:一项队列研究

Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study.
PubMed 文献 · Diabetes Care · 2021-01-06

该研究基于挪威全国人群队列,纳入299例儿童期起病1型糖尿病受试者,平均年龄33岁、糖尿病病程24年,随访至2017年底。在295例受试者中,40例(13.6%)发生冠心病事件,平均随访14.4年。调整传统危险因素后,IL-6、半乳糖凝集素-3和TIMP-1均为冠心病的显著预测因子。

要点

  • 半乳糖凝集素-3每增加1个标准差,冠心病风险调整后HR为1.44(95%CI 1.09-1.80)。
  • IL-6和TIMP-1亦为显著预测因子,调整后HR分别为1.32和1.37。
  • 半乳糖凝集素-3或可辅助传统危险因素预测1型糖尿病患者的冠心病风险。

核心结论

  • 在长期儿童期起病1型糖尿病受试者中,血清半乳糖凝集素-3与未来冠心病事件显著相关。
  • 若结果在更大规模研究中被重复,半乳糖凝集素-3可能辅助传统危险因素用于冠心病预测。

研究设计与样本

  • 基于挪威全国人群的队列研究,纳入1973-1982年诊断时年龄<15岁的1型糖尿病受试者299例,2002-2003年检查时平均年龄33岁(范围21-44),平均糖尿病病程24年(范围19-30)。
  • 296例有储存血清样本,检测IL-6、IL-6受体、IL-18、hs-CRP、基质金属蛋白酶-9、TIMP-1、半乳糖凝集素-3和高敏肌钙蛋白T。
  • 采用Cox回归估计生物标志物每增加1个标准差的调整风险比(aHR)。

主要发现

  • 295例受试者中,40例(13.6%)在平均14.4年随访(范围0.5-16)期间发生确诊冠心病事件。
  • 调整传统危险因素后,IL-6(aHR 1.32 [95%CI 1.07-1.63])、半乳糖凝集素-3(aHR 1.44 [95%CI 1.09-1.80])和TIMP-1(aHR 1.37 [95%CI 1.04-1.81])为冠心病的显著预测因子。

临床怎么用

  • 对于长期儿童期起病1型糖尿病患者,可关注半乳糖凝集素-3等炎症生物标志物以辅助冠心病风险分层。
  • 目前半乳糖凝集素-3的预测价值需在更大规模研究中验证后方可用于临床常规预测。

局限性

  • 研究样本量较小(295例),冠心病事件数有限(40例)。
  • 结果需在更大规模研究中重复验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study whether serum galectin-3 and other biomarkers of inflammation predict coronary heart disease (CHD) in subjects with long-standing childhood-onset type 1 diabetes. RESEARCH DESIGN AND METHODS: A population-based nationwide cohort of 299 subjects with type 1 diabetes diagnosed in Norway at <15 years of age during 1973-1982 was examined in 2002-2003 at a mean age of 33 years (range 21-44), with mean diabetes duration of 24 years (range 19-30). Subjects were followed through 31 December 2017 for their first CHD event registered by a hospitalization or cause of death using nationwide registries. Stored serum samples were available for 296 subjects and analyzed for interleukin-6 (IL-6), IL-6 receptor, IL-18, hs-CRP, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1), galectin-3, and high-sensitivity troponin T. Adjusted hazard ratios (aHRs) for CHD per SD increase in biomarker were estimated using Cox regression. RESULTS: Of 295 subjects, 40 (13.6%) had a documented CHD event during a mean follow-up of 14.4 years (range 0.5-16). IL-6 (aHR 1.32 [95% CI 1.07-1.63]), galectin-3 (aHR 1.44 [95% CI 1.09-1.80]), and TIMP-1 (aHR 1.37 [95% CI 1.04-1.81]) were significant predictors of CHD after adjustment for conventional risk factors. CONCLUSIONS: Galectin-3 was significantly associated with future CHD in subjects with type 1 diabetes, and if the results are replicated in larger studies, it may aid in prediction together with conventional risk factors for CHD.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Saeed M, Tapia G, Ariansen I, et al. Serum Galectin-3 and Subsequent Risk of Coronary Heart Disease in Subjects With Childhood-Onset Type 1 Diabetes: A Cohort Study. Diabetes Care. 2021. PMID: 33408220. doi:10.2337/dc20-1712

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。